KIN2.DEKIN2.DEXETRA
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+119.7%
5Y CAGR+20.9%
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

3Y CAGR
+119.7%/yr
Annual compound
5Y CAGR
+20.9%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$2.57B+100.9%
2024$1.28B+152.1%
2023$507.00M+109.3%
2022$242.20M+66.5%
2021$145.50M-85.4%
2020$993.60M+730.1%
2019$119.70M+147.0%
2018$-254.70M-571.7%
2017$54.00M-88.4%
2016$465.40M-